Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G48566-50 | 50 µg | $403 |
Human IDO1 / IDO Protein (Recombinant) (Ala2-Gly403) - LS-G48566
Human IDO1 / IDO Protein (Recombinant) (Ala2-Gly403) - LS-G48566
Available for shipment within the USA only
Description:
IDO1 / IDO Protein LS-G48566 is a Recombinant Human IDO1 / IDO produced in E. coli Ala2-Gly403. It is biologically active. For Research Use Only
Available for USA Shipment Only
Toll Free North America
206-374-1102
206-374-1102For Research Use Only
Overview
Description:
IDO1 / IDO Protein LS-G48566 is a Recombinant Human IDO1 / IDO produced in E. coli Ala2-Gly403. It is biologically active. For Research Use Only
Specifications
Type
Recombinant Protein
Target
IDO1 / IDO
Synonyms
IDO1 | IDO | Indole 2,3-dioxygenase | Indolamine 2,3 dioxygenase | IDO-1 | INDO | Indoleamine 2,3-dioxygenase | Indoleamine 2,3-dioxygenase 1
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Applications
- Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Region
Ala2-Gly403
Predicted Molecular Weight
The recombinant human IDO1 consists of 403 amino acids and predicts a molecular mass of 45.2 kDa. It migrates as an approximately 46 kDa band in SDS-PAGE under reducing conditions.
Expression System
E. coli
Source Species
E. coli
Purification
> 85 % as determined by SDS-PAGE
Bio-Activity
Measured by its ability to oxidize L-tryptophan to N-formylk-ynurenine.The specific activity is > 500 pmoles/min/µg.
Endotoxin
Not Tested
Presentation
Sterile 50 mM NaAC, 100 mM Nacl, 20 % glycerol, pH 5.5.
Storage
Aliquot and store at -20°C to -80°C for one year. Avoid repeated freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Available for shipment within the USA only
About IDO1 / IDO
Publications (0)
Customer Reviews (0)
Images
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Popular IDO1 / IDO Proteins
Source:
Yeast
Tag:
6His, N-terminus
Source:
Human
Tag:
Myc-DDK (Flag)
Source:
E. coli
Tag:
His, N-Terminal
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/25/2024
Date Requested: 4/25/2024
